Skip to main content
An official website of the United States government

Cancer Immunoprevention Network (CIP-Net)

An image of T cells interacting with dendritic cells.

A dendritic cell (blue) showing T cells (red) what antigens to look for. This helps T cells find cancer cells and infected cells.

Credit: National Institute of Allergy and Infectious Diseases

An emerging scientific opportunity is the development of approaches that leverage the immune system to prevent cancers. Further, an NCI Board of Scientifc Advisors (BSA) Ad Hoc Working Group encouraged fostering “novel and innovative research designs….to expedite progress in precision prevention.

The Cancer Immunoprevention Network (CIP-Net), supported by DCB and the NCI Division of Cancer Prevention, aims to support a deeper understanding of basic mechanisms of immunoprevention, to promote the discovery of novel immunoprevention strategies, and to foster a community of cancer immunoprevention researchers.

Additional details about the network can be found on NCI Division of Cancer Prevention webpages about CIP-Net.   

  • RFA-CA-23-029: Cancer Immunoprevention Network (CIP-Net) Research Projects (UG3/UH3 Clinical Trials Not Allowed)
  • Recording from a CIP-Net pre-application webinar

CIP-Net News

NCI Program Directors recently gave presentations about CIP-Net at the SITC Immunoprevention Virtual Summit and as part of an NCI/NIH Session at AACR 2023.  

DCB Contact for CIP-Net

For additional information about CIP-Net, please contact Dr. Lillian Kuo.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Immunoprevention Network (CIP-Net) was originally published by the National Cancer Institute.”